The arrival of Semaglutide at a 45mg dose represents a notable step forward in addressing type 2 diabetes. Previously, reduced doses were commonly used, but this additional formulation provides the possibility for greater glucose regulation in many individuals. Doctors are assessing its effectiveness and well-being profile, especially in patient… Read More